Hepatitis C
Showing NaN - NaN of 57
HCV-TARGET- Hepatitis C Therapeutic Registry and Research
Active, not recruiting
- Hepatitis C
-
Phoenix, Arizona
- +59 more
Oct 5, 2022
Zepatier in Patients With Substance Use
Active, not recruiting
- Hepatitis C
- +3 more
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jun 28, 2022
Renal Failure Chronic, Hepatitis C Trial in United States (glecaprevir/pibrentasvir treatment)
Completed
- Renal Failure Chronic
- Hepatitis C
- glecaprevir/pibrentasvir treatment
-
Chicago, Illinois
- +6 more
Jan 18, 2022
Studying the Implementation of Clinical Pharmacogenomic Testing
Recruiting
- Patients Undergoing Routine Health Care
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Jan 7, 2022
HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin
Terminated
- HIV Infections
- Hepatitis C
- Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
- +2 more
-
Birmingham, Alabama
- +15 more
Nov 2, 2021
HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))
Completed
- HIV Infections
- Hepatitis C
- Pegylated-Interferon Alfa 2b (PEG-IFN)
- +2 more
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
An Observational Study of Hepatitis C Virus in Pregnancy
Completed
- Hepatitis C
-
Birmingham, Alabama
- +16 more
Sep 21, 2021
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
Hepatitis C, HIV, AIDS Trial in United States (Control Group, Care Facilitation Group)
Completed
- Hepatitis C
- +3 more
- Control Group
- Care Facilitation Group
-
Birmingham, Alabama
- +10 more
Jul 21, 2020
Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)
Completed
- Hepatitis C
- HCV
- Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
- Ribavirin 200Mg Tablet
-
Palo Alto, California
- +30 more
Feb 17, 2020
Subjects Who Participated inPrevious Asunaprevir and/or
Completed
- Hepatitis C
- Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052)
-
Montgomery, Alabama
- +160 more
Nov 26, 2019
Adult-to-Adult Living Donor Transplant Cohort Study
Completed
- Liver Diseases
- +4 more
-
San Francisco, California
- +8 more
Feb 7, 2019
Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure Trial in United States (drug, procedure, other)
Completed
- Hepatitis C
- +2 more
- calcineurin inhibitor-based immunosuppression
- +3 more
-
San Francisco, California
- +7 more
Jan 15, 2019
Adult-to-Adult Living Donor Liver Transplantation Study
Completed
- Cirrhosis
- +2 more
-
Los Angeles, California
- +8 more
Aug 27, 2017
